PTGS2 and Burkitt lymphoma: Several studies revealed that inhibition of COX-2 by celecoxib in Burkitt's lymphoma cell lines RAJI, BjAB, (Epstein-Barr virusnegative), and BL41 led to a reduction of cell proliferation [34].